Author: Jianjian Wang; Yuyi Tang; Yanfang Ma; Qi Zhou; Weiguo Li; Muna Baskota; Yinmei Yang; Xingmei Wang; Qingyuan Li; Xufei Luo; Toshio Fukuoka; Hyeong Sik Ahn; Myeong Soo Lee; Zhengxiu Luo; Enmei Liu; Yaolong Chen
Title: Efficacy and Safety of Antibiotic Agents in Children with COVID-19: A Rapid Review Document date: 2020_4_17
ID: jubwcobb_54
Snippet: There is no direct evidence to support the efficacy of antibiotic agents in children with COVID-19. A high proportion of patients with COVID-19 were treated with antibiotics, despite the lack of etiological evidence. Current evidence suggests that secondary bacterial infections such as Acinetobacter baumannii and Klebsiella pneumoniae may occur in COVID-19 patients, and antibiotic agents are widely used in the clinical treatment of COVID-19. For .....
Document: There is no direct evidence to support the efficacy of antibiotic agents in children with COVID-19. A high proportion of patients with COVID-19 were treated with antibiotics, despite the lack of etiological evidence. Current evidence suggests that secondary bacterial infections such as Acinetobacter baumannii and Klebsiella pneumoniae may occur in COVID-19 patients, and antibiotic agents are widely used in the clinical treatment of COVID-19. For SARS, evidence suggests that early use of antibiotics has no effect on the clinical outcomes, but the use of broad-spectrum antibiotics increased the risk of dysbacteriosis, which can cause nosocomial infections. However, when bacterial infections are identified, rational use of antibiotic agents showed valid results in relieving symptoms and reducing the leukocyte count.
Search related documents:
Co phrase search for related documents- Acinetobacter baumannii and bacterial infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- Acinetobacter baumannii and broad spectrum: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- Acinetobacter baumannii and broad spectrum antibiotic: 1, 2, 3, 4
- Acinetobacter baumannii and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8
- Acinetobacter baumannii and clinical treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9
- Acinetobacter baumannii and high proportion: 1, 2
- Acinetobacter baumannii and Klebsiella pneumoniae: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- Acinetobacter baumannii and Klebsiella pneumoniae Acinetobacter baumannii: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58
- Acinetobacter baumannii and leukocyte count: 1
- Acinetobacter baumannii and nosocomial infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- Acinetobacter baumannii and nosocomial infection cause: 1, 2
- antibiotic agent and bacterial infection: 1
- antibiotic agent and nosocomial infection: 1
Co phrase search for related documents, hyperlinks ordered by date